Medivation's common stock is publicly traded on the Nasdaq Global Market under the symbol "MDVN". The Company's stock previously traded on the American Stock Exchange under the trading symbol "MDV".
Medivation currently does not offer a direct stock purchase or dividend reinvestment program. We currently intend to retain any future earnings to fund the development and expansion of our business, and therefore do not anticipate paying any cash dividends on Common Stock in the foreseeable future. Any future determination to pay dividends will be at the discretion of our Board of Directors.
Medivation was incorporated in Delaware in October 1995. However, we did not conduct any substantive business operations prior to our acquisition of Medivation Neurology, Inc. on December 17, 2004.
The transfer agent is responsible for maintaining all records of registered stockholders (including change of address, telephone number and name), canceling or issuing stock certificates, and resolving problems related to lost, destroyed or stolen certificates. If your shares are held in Street name (i.e. by your broker), you must contact your broker for these services.
If your shares are held in your name, you may contact American Stock Transfer & Trust Company at (800) 937-5449 or www.amstock.com. If your shares are held in Street name (i.e. by your broker), you must contact your broker to update your address.